from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3035/-

LFCtreatmentdescriptionclass of inhibitor

-0.794

Amikacinug/mL Amikacintranslation

-0.609

Cap5-10ug/mL Capreomycintranslation

-1.114

Rox10-50 ug/mL Roxithromycintranslation

0.061

SM2-5 ug/mL Streptomycintranslation

2.780

Tet5-10 ug/mL Tetracyclinetranslation

1.032

Rif0.2-5ug/mL Rifampicintranscription

0.824

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.185

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.070

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.004

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.753

Clofazimine10-13 ug/mL Clofaziminerespiration

0.009

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.476

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.065

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.628

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.088

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.422

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.254

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.559

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.284

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.649

KCN5-20 ug/mL Potassium cyaniderespiration

0.199

NaN30.2-2 mM Sodium aziderespiration

-0.077

Nigericin50 uM Nigericinrespiration

-0.084

TRC10-150 ug/mL Triclosanrespiration

-0.080

TRZ10-25 ug/mL Thioridazinerespiration

-1.847

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.010

menadione6-10 ug/mL Menadionerespiration

-0.013

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.102

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.228

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.319

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.176

NRP_1Non-replicating persistence stage 1dosRassociated

0.039

Amp0.2mg/mL AmpicillincellWall

0.223

Cephalexin20-100 ug/mL CephalexincellWall

0.503

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.254

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.110

EMB10-20 ug/mL EthambutolcellWall

0.403

Eta12-40 ug/mL EthionamidecellWall

0.369

INH0.2-0.4 ug/mL IsoniazidcellWall

0.082

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.276

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.333

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.117

BZA0.12 mg/mL BenzamidearomaticAmides

0.333

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.141

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.374

H2O24 mM hydrogen peroxideDNAdamaging

-0.218

Levo10 ug/mL LevofloxacinDNAdamaging

0.489

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.750

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.406

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.645

UVUV-irradiationDNAdamaging

-0.429

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.604

Antimycin12.5-50 ug/mL Antimycin A?

-0.454

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.238

PA_110-50 ug/mL Antitubercular compound PA-1?

0.160

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.435

PA8240.2-2 ug/mL PA-824?

0.465

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.204

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.682

Verapamil50 uM Verapamil?

0.057

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.079

methoxatin10-20 ug/mL Methoxatin?